Human Life CORD JAPAN
  • Top
  • Corporate Information | Members

Corporate InformationMembers

Directors & Auditors

As a company with an audit and supervisory board, the composition ratio of outside directors is high, and we have established an advanced management system for a startup company.

Director

Founder, Representative Director
President and CEO, Chairman of the board
Masamitsu HarataMaster of Agriculture, Master of Business Administration

Experienced all the necessary elements for a start-up under a global environment, such as basic research in academia, clinical development at listed pharmaceutical companies in Japan and overseas, medical affairs, sales marketing and management prior to establishing Human Life CORD Co., Ltd.
Invited Teaching Staff Part-time Lecturer) at the Aging Research Field, Graduate School of Medical Science, Nagoya University

2017
Established Human Life CORD Co., Ltd. Appointed President and Representative Director
2015
SymBio Pharmaceuticals Limited Executive Officer and General Manager of Business Development & Businesses Marketing Division
2014
Acquired MBA in New York
2007
Celgene Corporation Marketing, Medical & Clinical Development Division
2000
Clinical Development Department, Amgen Co., Ltd.
Researcher (concurrent) in the Molecular Therapy Research Field, The Institute of Medical Sciences, the University of Tokyo
1998
Clinical Development Department, Drug Research Laboratories, Nippon Kayaku Co., Ltd.
1996
Researcher, Institute of Life Engineering and Industrial Technology, Ministry of International Trade and Industry

Director of Overseas Business PlanningAndy C. Ye

As a global management consultant, he has many connections in the U.S. and other parts of Asia. Multi-lingual. In charge of global business development, starting with the U.S.

2017
Human Life Cord Inc. –Independent Director
2007
Perella Weinberg Partners -Director
2005
Xerion Capital Partner -Head Trader
2001
Lockheed Martin -as the youngest employee selected into ELDP
2000
The National Institute for Occupational Safety and Health
-Center for Disease Control And Prevention of United States government
1999
Mylan Pharmaceuticals

Outside Director

Norio Tahara

2022
Nihon Trim Co., Ltd. President and Representative Director
2020
Human Life CORD Japan Inc. Outside Director
2019
Nihon Trim Co., Ltd. Senior Managing Director, General Manager of Administrative Headquarters and General Manager of Corporate Planning
2018
Nihon Trim Co., Ltd. Director, General Manager of Administrative Headquarters and General Manager of Corporate Planning
2017
Nihon Trim Co., Ltd. Director, General Manager of Corporate Planning
2014
Nihon Trim Co., Ltd. Executive Officer, General Manager of Corporate Planning
2013
Nihon Trim Co., Ltd. General Manager of Corporate Planning
2003
Joined Nippon Trim Co., Ltd.

Akira Nabeshima

2023
Human Life CORD., Ltd. Outside Director (concurrent)
2023
Alfresa Holdings Corporation
General Manager of Regenerative Medicine Business Planning and Development, Total Supply Chain Service Planning and Development Department(current position)
2022
Alfresa Corporation General Manager of Business Development(current position)
2022
Alfresa Corporation Manager of Business Development Group, Corporate Planning Department
2019
Alfresa Corporation Manager of Kyoto Hospital Branch, Kyoto & Shiga Sales Department
2015
Alfresa Corporation Manager of Sales Group, Hospital Management Department
2011
Alfresa Corparation Manager of Hospital Central Branch, Tokyo Hospital Second Sales Department
1994
Joined Fukujin Co., Ltd.

Hiroshi Ishiai

2022
Human Life CORD Japan Inc. Outside Director (concurrent)
2017
Joined DBJ Capital Co., Ltd.
2011
Joined Astellas Pharma Inc.

Yoshihiro Kidachi

2021
Human Life CORD Japan Inc. Outside Director (concurrent)
2020
Human Life CORD Japan Inc. Outside Auditor
2017
Human Life CORD Japan Inc. Participated as Management Strategy Advisor
2012
Boise Craft Co., Ltd. Representative Director
2003
Mitsui Sumitomo Insurance Capital Co., Ltd.
1993
Dai-Ichi Kangyo Bank, Ltd. (currently Mizuho Bank)

Tetsuo Yamanaka

2020
TOITOMA Inc. Returned as President and Representative Director
2019
Outside Director (concurrent), Human Life CORD Japan Inc.
2018
Human Life CORD Japan Inc. Chairman of the Board
2008
Established TOITOMA Inc. Representative Director
2007
Established a consulting firm in Hawaii, U.S., and CEO

Nobutoshi Matsushita

2022
Human Life CORD Japan Inc. Outside Director (concurrent)
2017
Merk Serono (currently Merk) Director, General Manager of Research and Development
2016
Merk Serono (currently Merk) General Manager of Research and Development
2015
Joined Merk Serono (currently Merk)
2003
Joined Nihon Schering K.K. (currently Bayer)
2001
Joined DAINABOT CO., LTD. (currently AbbVie)
1997
Joined ROHTO Pharmaceutical Co., Ltd.
1990
Joined Sumitomo Metal Industries, Ltd. (currently NIPPON STEEL CORPORATION)

Outside Auditor

Full-timeHiroshi Nakamura

2021
Human Life CORD Japan Inc. Full-time Auditor
2015
CMIC HOLDINGS Co., Ltd. Auditor
2013
JCL Bioassays Co., Ltd. Outside Director
2011
Konet Inc. President and Representative Director
2007
Institute of Applied Medicine, Inc. President and Representative Director
2004
Human Life CORD Japan Inc. Executive Vice President & CFO
2000
Joined CMIC HOLDINGS Co., Ltd.
2000
Joined Toyo Heat Industries, Ltd.
1970
Joined Koizumi Group Co., Ltd.
1966
Joined Koji Masuda CPA Office

Part-timeDaisuke Fujioka

2020
Human Life CORD Japan Inc. Outside Auditor (concurrent)
2018
Human Life CORD Japan Inc. Participated as Management Strategy Advisor
2015
YGA Partners Inc. Representative Director
2014
YCP Accounting Co., Ltd. Representative Director
2014
Yamato Capital Partners Co., Ltd. (currently YCP Japan Co., Ltd.)
2004
Ernst & Young ShinNihon LLC. Strategic Markets Department

Part-timeMaya Ito

2021
Human Life CORD Japan Inc. Outside Auditor
2016
Partner, Nishimura Asahi Law Office (current)
2012
Organization for Small & Medium Enterprises and Regional Innovation, JAPAN Lecturer, Institute for Small Business Management and Technology
2010
Surugadai Law School Part-time Lecturer
2007
Temporary transfer to Mizuho Corporate Bank, Ltd.
2002
Joined Nishimura Asahi Law Office
2002
Registration as a practicing attorney

Leadership Team

The leaders with strengths in each function required for the commercialization of regenerative medicine and other products are united in promoting the business.

ManagementMasamitsu HarataMaster of Agriculture, Master of Business Administration

Targeting therapy for intractable leukemia was studied as a researcher of the former Ministry of International Trade and Industry Institute of Industrial Science and Technology, and international results were obtained.
Experienced in the three elements necessary for the drug discovery bio start-up (basic research experience in academia/general administration of clinical development at a pharmaceutical company/management in bioventures) and global business experience.
Founded Human Life CORD Japan Inc. in April 2017, President and Representative Director

R&DMasamichi YamadaMaster of Engineering

Senior professional with extensive experience in drug research and development in the area of rare diseases. Prior to joining our team, he provided leadership and strategic vision at several global pharmaceutical companies. With a strong commitment to bringing cell therapy, a cutting-edge treatment modality, to patients, his team drives R&D and product launch in Human Life CORD.

Reliability AssuranceAkira FutakataPharmacist

Experienced regulatory affairs and quality assurance at various major chemical companies and pharmaceutical companies in Japan before joining our team.
Participated in the establishment of the organization for reliability assurance twice as a result of the company mergers, and experienced the three roles (Supervisor general, QA manager, and safety manager) at each company.
Responsible for regulatory filings and quality assurance for pharmaceutical formulations/active pharmaceutical ingredients, medical devices, and in vitro diagnostics, and has experience in launching new item products.
Provides business and management strategy support to management and is involved in business plan formulation

ManufacturingKentaro OkamuraPh.D. (Medicine)

Joined our team after experiences cell biology research at Japanese and overseas research institutes, research and development at Japanese and overseas multiple bio startup company, and cell manufacturing for regenerative medicine.
In collaboration with the Institute of Medical Science, the University of Tokyo, responsible for all aspects of manufacturing, such as launch and managiment of cell processing facilities, manufacture of investigational products, CMC regulatory, technology transfer to CMO, and manufacturing technology development.

Management Strategy and Business DevelopmentAkihito NakataPh.D. (Pharmacy), Pharmacist

Joined our team after experience at a foreign consulting firm, and supporting and investing in ventures in the fields of life sciences and healthcare.
In management consulting, he leads new businesses for major Japanese and overseas pharmaceutical and medical device companies, R&D, support for formulation and execution of organizational strategies, and various business reform projects.
In support of ventures, the company provides end-to-end support for Japanese business development activities of over 20 drug discovery ventures from Europe and the U.S.
Executive Director, NPO Corp. IHL/ Healthcare Leadership Study Group

CorporateYosuke Kotaki

After founding a medical and welfare-related company, he joined us after experiencing the management planning, accounting, finance, general affairs, legal affairs, etc. of JQ listed IT companies (now Prime Market) and JQ listed pharmaceutical companies (now TSE Growth Market).
Involved in M&A, financing, and formulating and executing medium-term business plans from the standpoint of both managers and employees, and contributes to improving business performance and achieve results by building an in-house sales system for drugs

Advisor

Hirotaka Yabuki

2017
Human Life CORD Japan Inc. Participated as Management Strategy Advisor
2010
Bain & Company
2009
"Senior Advisor at SanBio Company Limited
Janssen Pharmaceutical K.K.
Innovation Network Corporation of Japan"
1994
Boston Consulting Group

Keiya Ozawa

2018
Human Life CORD Japan Inc. Participated as Senior Medical Advisor
2018
Professor Emeritus and Visiting Professor, Jichi Medical University
2014
The Institute of Medical Science, the University of Tokyo Hospital Hospital Director
Division of Gene Therapy Development, Advanced Clinical Research Center
Professor
2011
Department of Immunogenetic Cell Therapy, Jichi Medical University
Professor Concurrent position
1998
Jichi Medical College Molecular Pathology Research Center
Professor of Genetic Therapeutics Division Concurrent position
1985
Overseas study at U.S. NIH
1979
Part-time medical staff, Department of Internal Medicine 3, The University of Tokyo

Tokiko Nagamura

2019
Human Life CORD Japan Inc. Participated as Medical Advisor
2017
Cord Blood/Cord Bank Head Concurrent position
2014
The Institute of Medical Science, the University of Tokyo
Cell Processing & Blood Transmission Department
Associate Professor and Department Head
2004
The Institute of Medical Science, the University of Tokyo
Cell Processing & Blood Transmission Department Instructor
1998
U.S. NIH Visiting Fellow
1990
Department of Hematology, the Institute of Medical Science, the University of Tokyo
Back to Top Page